Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2011-7-22
pubmed:abstractText
Endocytosis of tyrosine kinase receptors can influence both the duration and the specificity of the signal emitted. We have investigated the mechanisms of internalization of fibroblast growth factor receptor 3 (FGFR3) and compared it to that of FGFR1 which is internalized predominantly through clathrin-mediated endocytosis. Interestingly, we observed that FGFR3 was internalized at a slower rate than FGFR1 indicating that it may use a different endocytic mechanism than FGFR1. Indeed, after depletion of cells for clathrin, internalization of FGFR3 was only partly inhibited while endocytosis of FGFR1 was almost completely abolished. Similarly, expression of dominant negative mutants of dynamin resulted in partial inhibition of the endocytosis of FGFR3 whereas internalization of FGFR1 was blocked. Interfering with proposed regulators of clathrin-independent endocytosis such as Arf6, flotillin 1 and 2 and Cdc42 did not affect the endocytosis of FGFR1 or FGFR3. Furthermore, depletion of clathrin decreased the degradation of FGFR1 resulting in sustained signalling. In the case of FGFR3, both the degradation and the signalling were only slightly affected by clathrin depletion. The data indicate that clathrin-mediated endocytosis is required for efficient internalization and downregulation of FGFR1 while FGFR3, however, is internalized by both clathrin-dependent and clathrin-independent mechanisms.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-10556816, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-10806110, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-11809831, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-12717440, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-14607973, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-14699054, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-14985334, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-15590645, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-15634214, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-15701692, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-15863030, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-16053508, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-16091423, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-16720641, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-17609668, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-17944804, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-18480409, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-18694561, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-18719708, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-18793634, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-19050695, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-19247306, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-19317650, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-19461071, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-19696798, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-1975591, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-20094046, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-20107503, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-20110990, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-20125123, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-20833364, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-20837153, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-21047773, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-311005, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-6309862, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-7559787, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-7896867, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-8101525, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-8663044, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-8953040, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-9247306, http://linkedlifedata.com/resource/pubmed/commentcorrection/21779335-9811566
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1932-6203
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
e21708
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Clathrin- and dynamin-independent endocytosis of FGFR3--implications for signalling.
pubmed:affiliation
Centre for Cancer Biomedicine, Faculty Division Norwegian Radium Hospital, University of Oslo, Oslo, Norway.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't